+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "DNA Vaccines"

From
From
Viral Vectors and Plasmid DNA Global Market Report 2024 - Product Thumbnail Image

Viral Vectors and Plasmid DNA Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
From
From
From
From
From
Vaccines Markets in China - Product Thumbnail Image

Vaccines Markets in China

  • Report
  • July 2024
  • 326 Pages
  • China
From
Vaccines Industry Forecasts - China Focus - Product Thumbnail Image

Vaccines Industry Forecasts - China Focus

  • Report
  • July 2024
  • 187 Pages
  • China
From
SARS-CoV-2 COVID Vaccine Market Analysis & Forecast to 2026 - Product Thumbnail Image

SARS-CoV-2 COVID Vaccine Market Analysis & Forecast to 2026

  • Report
  • March 2021
  • 137 Pages
  • Global
From
Loading Indicator

DNA vaccines are a type of genomics-based vaccine that uses genetic material from a virus or bacteria to stimulate an immune response. They are created by introducing a gene that codes for a specific antigen into a plasmid, which is then inserted into a host cell. The host cell then produces the antigen, which is then used to stimulate an immune response. DNA vaccines are considered to be safer than traditional vaccines, as they do not contain any live virus or bacteria. Additionally, they can be produced more quickly and cheaply than traditional vaccines. DNA vaccines have been used to treat a variety of diseases, including influenza, malaria, and HIV. They have also been used to develop vaccines for cancer and other diseases. Recently, DNA vaccines have been used to develop vaccines for the prevention of infectious diseases, such as Zika virus and Ebola. Companies in the DNA Vaccines market include Moderna, Inovio Pharmaceuticals, Novavax, and Transgene. Show Less Read more